Tysabri 300 mg/15 mL injection for intravenous infusion Images
Generic Name: natalizumab
This medication has been identified as Tysabri 300 mg/15 mL injection for intravenous infusion. It is supplied by Biogen.
Tysabri is used in the treatment of Crohn's Disease, Maintenance; Multiple Sclerosis and belongs to the drug class selective immunosuppressants. Risk cannot be ruled out during pregnancy. Tysabri 300 mg/15 mL injection for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Tysabri
- Generic Name
- natalizumab
- Strength
- 300 mg/15 mL injection for intravenous infusion
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Biogen
- National Drug Code (NDC)
- 64406-0008
More about Tysabri (natalizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (97)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
